ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006

Should Be Cut First, DCT Board Says

December 4, 1981

Chemical Distribution To Grantees Delayed while HEW Considers Charging For It

June 22, 1979

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

Pilot Study Tests Novel “Metronomic” Delivery

December 30, 2005